Latest Trials

EudraCT Number: 2005-001201-25 Sponsor Protocol Number: RGH-896-004 Start Date: 2005-05-31
Sponsor Name: Gedeon Richter Ltd
Full Title: Phase II placebo-controlled study to evaluate the efficacy, safety and tolerability of RGH-896 in patients with pain due to diabetic sensorimotor peripheral neuropathy
Medical condition: Neuropathic pain in patients with diabetic peripheral neuropathy
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: GB (GB - no longer in EU/EEA)
Trial results: (No results available)
EudraCT Number: 2006-002179-41 Sponsor Protocol Number: Soluzioni CAPD Start Date: 2005-05-31
Sponsor Name: AZIENDA OSPEDALIERA POLICLINICO DI MODENA
Full Title: Studio aperto, randomizzato, controllato per valutare gli effetti di nuove soluzioni biocompatibili per Dialisi Peritoneale(poliglucosio, aminoacidi, bicarbonato/lattato)rispetto alle soluzioni sta...
Medical condition: Pazienti ambulatoriali
Disease: Version SOC Term Classification Code Term Level
6.1 10012658 HLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: IT (Prematurely Ended)
Trial results: (No results available)
EudraCT Number: 2008-006862-27 Sponsor Protocol Number: CIK Start Date: 2005-05-30
Sponsor Name: AZIENDA OSPEDALIERA "OSPEDALI RIUNITI DI BERGAMO" (A.O. DI RILIEVO NAZIONALE)
Full Title: Infusion of Cytokine Induced Killer (CIK) cells in patients relapsing after allogeneic stem cell transplantation
Medical condition: Patients with hematologic malignancies (excluding CML) with a hematologic or molecular relapse after allogeneic transplantation (at least 60 days should have elapsed since transplant).
Disease: Version SOC Term Classification Code Term Level
9.1 10005329 Blood and lymphatic system disorders SOC
Population Age: Children, Adolescents, Under 18, Adults, Elderly Gender: Male, Female
Trial protocol: IT (Completed)
Trial results: (No results available)
EudraCT Number: 2005-000963-25 Sponsor Protocol Number: A1481156 Start Date: 2005-05-30
Sponsor Name: Pfizer Limited, Ramsgate Road, Sandwich, Kent, UK
Full Title: A Multicenter, Long-Term Extension Study to Assess Safety of Oral Sildenafil in the Treatment of Subjects Who Have Completed Study A1481131
Medical condition: Pulmonary Arterial Hypertension
Disease: Version SOC Term Classification Code Term Level
14.1 10038738 - Respiratory, thoracic and mediastinal disorders 10064911 Pulmonary arterial hypertension PT
Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults Gender: Male, Female
Trial protocol: SE (Completed) GB (Completed) FI (Prematurely Ended) SK (Completed) Outside EU/EEA
Trial results: (No results available)
EudraCT Number: 2004-001216-31 Sponsor Protocol Number: SAG-26/UCA Start Date: 2005-05-30
Sponsor Name: Dr. Falk Pharma GmbH
Full Title: Double-blind, double-dummy, randomised, multicentre, comparative study of the efficacy and tolerability of once daily 3.0 g mesalazine granules versus three times daily 1.0 g mesalazine granules in...
Medical condition: Therapy of active ulcerative colitis
Disease: Version SOC Term Classification Code Term Level
7.1 10058816 LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: DE (Completed) LT (Completed) SK (Completed) HU (Completed) LV (Completed) CZ (Completed) EE (Completed) SI (Completed)
Trial results: View results
EudraCT Number: 2004-001616-31 Sponsor Protocol Number: OLM/CLIN/I-12/03 Start Date: 2005-05-27
Sponsor Name: LUSOFARMACO [...] 1. LUSOFARMACO 2. GUIDOTTI
Full Title: EFFICACY AND SAFETY OF OLMESARTAN IN ELDERLY PATIENTS WITH MILD TO MODERATE HYPERTENSION
Medical condition: patients of both sexes, aged 65-89 years and with mild-moderate essential arterial hypertension
Disease: Version SOC Term Classification Code Term Level
6.1 10020823 PT
Population Age: Elderly Gender: Male, Female
Trial protocol: IT (Completed)
Trial results: View results
EudraCT Number: 2005-000651-14 Sponsor Protocol Number: CSLCT-NHF-04-99 Start Date: 2005-05-27
Sponsor Name: CSL Limited
Full Title: A Single Site, Open-Label Study to Evaluate the Immunogenicity and Safety of Influenza Vaccine, CSL Limited in Healthy 'Adults' aged >18 to 60 years fo...
Medical condition: The vaccine is indicated for the prophylaxis of influenza
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: GB (Completed)
Trial results: View results
EudraCT Number: 2004-004358-24 Sponsor Protocol Number: MV18406 Start Date: 2005-05-27
Sponsor Name: F. Hoffmann-La Roche Ltd.
Full Title: A phase IIIb/IV randomised, controlled study evaluating an intensification treatment strategy of adding enfuvirtide (ENF) to an oral Highly Active AntiRetroviral Therapy (HAART) in treatment experi...
Medical condition: HIV Infection
Disease: Version SOC Term Classification Code Term Level
10020161
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: ES (Completed) DE (Completed) IT (Completed)
Trial results: View results
EudraCT Number: 2004-004120-12 Sponsor Protocol Number: AAB-001-202 Start Date: 2005-05-27
Sponsor Name: Elan Pharma Ltd
Full Title: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose, Safety, Tolerability, and Amyloid-Imaging Positron Emission Tomography (PET) Trial of AAB-001 (ELN116727) in Pa...
Medical condition: Alzheimer’s Disease
Disease: Version SOC Term Classification Code Term Level
5.1 10001897 HLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: GB (Completed) FI (Completed)
Trial results: (No results available)
EudraCT Number: 2004-005234-39 Sponsor Protocol Number: 2939111 Start Date: 2005-05-27
Sponsor Name: Orion Corporation, ORION PHARMA, Finland
Full Title: Multicentre, randomised, double-blind study to compare Stalevo® to levodopa/carbidopa in patients with Parkinson's disease experiencing symptoms of early wearing-off
Medical condition: Parkinson's disease
Disease: Version SOC Term Classification Code Term Level
7.0 10061536 LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: GB (Completed) SE (Completed) DK (Completed) FI (Completed) IE (Completed) DE (Completed) LT (Completed) LV (Completed)
Trial results: View results

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe